Together Pharma Ltd., headquartered in Israel, is a prominent player in the medical cannabis industry, specialising in the cultivation, production, and distribution of high-quality cannabis products. Founded in 2014, the company has rapidly established itself as a leader in the sector, focusing on innovative solutions that cater to both medical and recreational markets. With operations extending across various regions, Together Pharma is committed to delivering unique cannabis strains and products that meet stringent quality standards. Their core offerings include a diverse range of cannabis oils, flowers, and edibles, all designed to enhance patient care and consumer experience. Recognised for their commitment to research and development, Together Pharma has achieved significant milestones, positioning itself as a trusted name in the evolving landscape of medical cannabis.
How does Together Pharma Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Together Pharma Ltd's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Together Pharma Ltd, headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Together Pharma Ltd may still be in the early stages of developing its climate commitments or reporting frameworks. In the context of the industry, many companies are increasingly adopting science-based targets and engaging in initiatives such as the Science Based Targets initiative (SBTi) to align their operations with global climate goals. However, without specific commitments or emissions data, it is unclear how Together Pharma Ltd positions itself within these industry standards. As the company moves forward, establishing measurable targets and transparent reporting will be crucial for demonstrating its commitment to reducing carbon emissions and contributing to climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Together Pharma Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
